591 results on '"Deinum, Jaap"'
Search Results
52. CHANGES OF THE ZONA GLOMERULOSA IN HUMAN ADRENALS FROM BIRTH TO 40 YEARS OF AGE
53. The Hyperintense study: Assessing the effects of induced blood pressure increase and decrease on MRI markers of cerebral small vessel disease: Study rationale and protocol
54. Stepwise Treatment of Uncontrolled Hypertension (Stepwise-HTN): Study Design of a Cluster Randomised Controlled Trial in Primary Care
55. Congenital eyelid ptosis, decreased glomerular filtration, and orthostatic hypotension: Questions
56. Pharmacological treatment of aldosterone excess
57. Pre- versus post-operative untargeted plasma nuclear magnetic resonance spectroscopy metabolomics of pheochromocytoma and paraganglioma
58. PD07-07 PREDICTING SURGICAL OUTCOME IN POSTERIOR RETROPERITONEOSCOPIC ADRENALECTOMY BASED ON PREOPERATIVE PATIENT CHARACTERISTICS
59. PD07-02 STRUCTURAL CHANGES IN THE ZONA GLOMERULOSA IN HUMAN ADRENALS UNDER THE AGE OF 40
60. Monogenic forms of low-renin hypertension: clinical and molecular insights
61. Partial Adrenalectomy Carries a Considerable Risk of Incomplete Cure in Primary Aldosteronism
62. Improvement in quality of life and psychological symptoms after treatment for primary aldosteronism: Asian Cohort Study
63. Pre- Versus Post-Operative Untargeted Plasma Nuclear Magnetic Resonance Spectroscopy Metabolomics of Pheochromocytoma And Paraganglioma
64. Identification of Surgically Curable Primary Aldosteronism by Imaging in a Large, Multiethnic International Study
65. Adrenal venous sampling guided adrenalectomy rates in primary aldosteronism: results of an international cohort (AVSTAT)
66. Clinical presentation and long-term follow-up of dopamine beta hydroxylase deficiency
67. Targeted metabolomics as a tool in discriminating endocrine from primary hypertension
68. Is there still a place for adrenal venous sampling in the diagnostic localization of pheochromocytoma?
69. CARDIAC ARRHYTHMIAS IN HYPOKALEMIC PERIODIC PARALYSIS: HYPOKALEMIA AS ONLY CAUSE?
70. The cardioprotective effects of mineralocorticoid receptor antagonists
71. Improvement in Quality of Life and Psychological Symptoms After Treatment for Primary Aldosteronism
72. A comparison of high‑throughput plasma NMR protocols for comparative untargeted metabolomics (Metabolomics
73. Glucocorticoid excess in patients with pheochromocytoma compared to paraganglioma and other forms of hypertension
74. Drug-resistant hypertension in primary aldosteronism patients undergoing adrenal vein sampling: the AVIS-2-RH study
75. The efficacy of renal angioplasty in patients with renal artery stenosis and flash oedema or congestive heart failure: a systematic review
76. The Adrenal Vein Sampling International Study (AVIS) for Identifying the Major Subtypes of Primary Aldosteronism
77. γ-Adducin Stimulates the Thiazide-sensitive NaCl Cotransporter
78. Targeted Metabolomics as a Tool in Discriminating Endocrine From Primary Hypertension
79. Clinical presentation and long‐term follow‐up of dopamine beta hydroxylase deficiency
80. Adrenal Venous Sampling–Guided Adrenalectomy Rates in Primary Aldosteronism: Results of an International Cohort (AVSTAT)
81. Pheochromocytoma Concealed By Chronic Methamphetamine Abuse
82. Mass spectrometry reveals misdiagnosis of primary aldosteronism with scheduling for adrenalectomy due to immunoassay interference
83. Glucocorticoid Excess in Patients with Pheochromocytoma Compared with Paraganglioma and Other Forms of Hypertension
84. Vasculometabolic and Inflammatory Effects of Aldosterone in Obesity
85. SAT-547 Aldosterone-Potassium Ratio Predicts Primary Aldosteronism Subtype
86. Low Quality of Reports on Blood Pressure in Patients Adrenalectomized for Unilateral Primary Aldosteronism
87. N-of-1 Trials: Evidence-Based Clinical Care or Medical Research that Requires IRB Approval? A Practical Flowchart Based on an Ethical Framework
88. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis
89. Systematic Review: Diagnostic Procedures to Differentiate Unilateral From Bilateral Adrenal Abnormality in Primary Aldosteronism
90. Drug-resistant hypertension in primary aldosteronism patients undergoing adrenal vein sampling: the AVIS-2-RH study.
91. Dopamine β-Hydroxylase Deficiency
92. Why Physicians Participate in Executions
93. Angiotensin converting enzyme insertion/deletion polymorphism and the risk of heart failure in hypertensive subjects
94. Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy: Interaction with ACE insertion/deletion genotype?
95. Optimal dose of losartan for renoprotection in diabetic nephropathy
96. Predictors for Clinical Success at One Year Following Renal Artery Stent Placement
97. Functional effects of renal artery stent placement on treated and contralateral kidneys
98. Renoprotective effects of losartan in diabetic nephropathy: Interaction with ACE insertion/deletion genotype?
99. Epstein-Barr Viral Load Assessment in Immunocompetent Patients With Fulminant Infectious Mononucleosis
100. Cystatin for estimation of glomerular filtration rate?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.